Does RUXOLITINIB Cause Wrong technique in product usage process? 909 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 909 reports of Wrong technique in product usage process have been filed in association with RUXOLITINIB (OPZELURA). This represents 1.3% of all adverse event reports for RUXOLITINIB.
909
Reports of Wrong technique in product usage process with RUXOLITINIB
1.3%
of all RUXOLITINIB reports
56
Deaths
158
Hospitalizations
How Dangerous Is Wrong technique in product usage process From RUXOLITINIB?
Of the 909 reports, 56 (6.2%) resulted in death, 158 (17.4%) required hospitalization, and 11 (1.2%) were considered life-threatening.
Is Wrong technique in product usage process Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 909 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Wrong technique in product usage process?
EVOLOCUMAB (21,664)
ALBUTEROL (17,114)
ADALIMUMAB (11,766)
PEGFILGRASTIM (10,217)
ETANERCEPT (9,835)
ERENUMAB-AOOE (9,359)
SACUBITRIL\VALSARTAN (8,022)
LEUPROLIDE (5,062)
FENTANYL (2,812)
SEMAGLUTIDE (2,538)
Which RUXOLITINIB Alternatives Have Lower Wrong technique in product usage process Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE